TrialAssure has released its latest version of ANONYMIZE for Documents, including the functionality to anonymize and redact PDF documents concurrently.
TrialAssure ANONYMIZE for Documents is a document redaction and anonymization software that combines machine learning—a form of artificial intelligence—and natural language processing to protect patient privacy by automatically finding, masking, anonymizing, or removing personal or company confidential information from unstructured text.
“We are seeing a dramatic increase in the need for clinical trial sponsors to complete new and retrospective anonymization of clinical documents,” said Kelly Vaillant, Director of Global Transparency Strategy & Compliance, TrialAssure. “The impetus for document anonymization comes as increasing regulations from global health authorities and added pressure from advocacy groups push for the expanded utility of data for secondary research.”
To learn more, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.